Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

TIMESPAN

Financiado

Management of chronic cardiometabolic disease and treatment discontinuity in adu...

Management of chronic cardiometabolic disease and treatment discontinuity in adult ADHD patients TIMESPAN's main objective is to advance the management of patients with Attention Deficit Hyperactivity Disorders (ADHD) and co-occurring cardiometabolic disease by improving available treatments and risk stratification. Emerging... ver más

31/03/2026

ORU

7M€

Presupuesto del proyecto: 7M€

Líder del proyecto

OREBRO UNIVERSITY No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 21 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-01-25

SC1-DTH-12-2020: Use of Real-World Data to advance r...

I+D

Cerrada hace 4 años

0% 88% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

21 Participantes

ORU

366.75K€ | Lider

ORGANIZACION FARMACEUTICA

University of Iceland

100.00K€ | Participante

HVL

400.00K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

EUIN2013-50870 MEDICINA PREDICTIVA PARA LA GESTION INTEGRAL DE CONDICIONES... 15K€ Cerrado

DyNPI-T2D Dynamic Modeling of Non-Pharmacological Interventions for Ty... 223K€ Cerrado

EMIF European Medical Information Framework 56M€ Cerrado

RECOVER REcasting psychological interventions for Customizing, Optim... 265K€ Cerrado

TIN2014-53067-C3-3-R DISEÑO DE UNA VIA CLINICA DE PATOLOGIAS CRONICAS COMO LA HIP... 16K€ Cerrado

RTC-2016-5609-1 Simulación de itinerarios de atención de pacientes crónicos... 264K€ Cerrado

Duración del proyecto: 62 meses Fecha Inicio: 2021-01-25
Fecha Fin: 2026-03-31

Líder del proyecto

OREBRO UNIVERSITY No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 7M€

Descripción del proyecto TIMESPAN's main objective is to advance the management of patients with Attention Deficit Hyperactivity Disorders (ADHD) and co-occurring cardiometabolic disease by improving available treatments and risk stratification. Emerging evidence points at substantial comorbidity and shared genetics between adult ADHD and cardiometabolic diseases (i.e., Obesity, Type-2 Diabetes and cardiovascular disease). Inadequate treatment of cardiometabolic disease is strongly associated with premature death and substantial societal costs. National guidelines of cardiometabolic disease have stressed the importance of co-occurring psychiatric disorders. However, even though ADHD is a common (prevalence ≈2 to 5% in adults) and serious complex chronic condition, knowledge about appropriate management of adults with ADHD and co-occurring cardiometabolic disease is lacking. We will address the main objective using existing large-scale cohort studies and linked electronic health record databases in multiple countries with different health care systems. We also use smartphones and wearable devices to obtain novel real-time and multi-parametric measurements of ADHD medication treatment and cardiometabolic risks. The combined use of unparalleled data sources and new technologies for data collection, management, analytics will identify optimized and personalized multidisciplinary treatment approaches that minimise harm and maximise positive changes in disease prognosis and improve treatment discontinuity. TIMESPAN is expected to improve the clinical outcomes, as well as quality of life in adult ADHD patients with co-occurring cardiometabolic disease and also to also facilitates developments of new technological tools for advanced data management, monitoring and analytics for European stakeholders. TIMESPAN strategies to inform clinicians, patients, health authorities, and general public allow for a sustainable implementation of our findings (e.g. recommendations for treatment guidelines).

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores